{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:49:33Z","timestamp":1760622573174},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1007\/s11886-004-0042-7","type":"journal-article","created":{"date-parts":[[2007,5,26]],"date-time":"2007-05-26T08:19:24Z","timestamp":1180167564000},"page":"385-390","source":"Crossref","is-referenced-by-count":6,"title":["New approaches to the treatment and prevention of neurally mediated reflex (neurocardiogenic) syncope"],"prefix":"10.1007","volume":"6","author":[{"given":"Daniel P.","family":"Melby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph A.","family":"Cytron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Benditt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"42_CR1","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1053\/euhj.2001.2739","volume":"22","author":"M Brignole","year":"2001","unstructured":"Brignole M, Alboni P, Benditt DG, et al.: Guidelines on management (bddiagnosis and treatment) of syncope. Eur Heart J 2001, 22:1256\u20131306. The ESC Task Force on Syncope provides the most important single reference source for recommended approaches to diagnosis and treatment of all forms of syncope. This document is updated periodically, and provides ready access to the most important literature on the subject.","journal-title":"Eur Heart J"},{"key":"42_CR2","first-page":"3","volume-title":"The Evaluation and Treatment of Syncope. A Handbook for Clinical Practice.","author":"J-J Blanc","year":"2003","unstructured":"Blanc J-J, Benditt DG: Syncope: definition, classification, and multiple potential causes. In The Evaluation and Treatment of Syncope. A Handbook for Clinical Practice. Edited by Benditt DG, Blanc J-J, Brignole M, Sutton RS. Elmsford, NY: Futura\/Blackwell; 2003:3\u201310."},{"key":"42_CR3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0735-1097(96)00236-7","volume":"28","author":"DG Benditt","year":"1996","unstructured":"Benditt DG, Ferguson DW, Grubb BP, et al.: Tilt table testing for assessing syncope. ACC expert consensus document. J Am Coll Cardiol 1996, 28:263\u2013275.","journal-title":"J Am Coll Cardiol"},{"key":"42_CR4","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJMoa012407","volume":"347","author":"ES Soteriades","year":"2002","unstructured":"Soteriades ES, Evans JC, Larson MG, et al.: Incidence and Prognosis of Syncope. N Engl J Med 2002, 347:878\u2013885. This manuscript, based on Framingham data, provides important insight into the natural history of syncope. The reader must beware, however, that the authors of the report mistakenly include neurologic causes of syncope, suggesting that they have not clearly separated syncope from other nonsyncope causes of transient loss of consciousness such as seizures. With that caveat in mind, the report does provide important follow-up information of clinical value.","journal-title":"N Engl J Med"},{"key":"42_CR5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2125.1999.00961.x","volume":"48","author":"SD Singh","year":"1999","unstructured":"Singh SD, Williams AJ: The prevalence and incidence of medical conditions in healthy pharmaceutical company employees who volunteer to participate in medical research. Br J Clin Pharmacol 1999, 48:25\u201331.","journal-title":"Br J Clin Pharmacol"},{"key":"42_CR6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1540-8159.2000.tb00833.x","volume":"23","author":"T Reybrouck","year":"2000","unstructured":"Reybrouck T, Heidbuchel H, Van de Werf F, et al.: Tilt training: a treatment for malignant and recurrent neurocardiogenic syncope. Pacing Clin Electrophysiol 2000, 23:493\u2013498. A landmark report introducing tilt training as a useful strategy in the treatment of neurally mediated reflex faints.","journal-title":"Pacing Clin Electrophysiol"},{"key":"42_CR7","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1161\/01.CIR.100.17.1798","volume":"100","author":"E Girolamo Di","year":"1999","unstructured":"Di Girolamo E, Di Iorio C, Leonzio L, et al.: Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents: a controlled study. Circulation 1999, 100:1798\u20131801.","journal-title":"Circulation"},{"key":"42_CR8","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1046\/j.1460-9592.2002.01454.x","volume":"25","author":"H Abe","year":"2002","unstructured":"Abe H, Kondo S, Kohshi K, et al.: Usefulness of orthostatic self-training for the prevention of neurocardiogenic syncope. Pacing Clin Electrophysiol 2002, 25:1454\u20131458.","journal-title":"Pacing Clin Electrophysiol"},{"key":"42_CR9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1081\/CEH-120025332","volume":"25","author":"H Abe","year":"2003","unstructured":"Abe H, Kohshi K, Nakashima Y: Efficacy of orthostatic selftraining in medically refractory neurocardiogenic syncope. Clin Exper Hypertens 2003, 25:487\u2013493.","journal-title":"Clin Exper Hypertens"},{"key":"42_CR10","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1046\/j.1460-9592.2002.01441.x","volume":"25","author":"T Reybrouck","year":"2002","unstructured":"Reybrouck T, Heidbuchel H, Van de Werf F, et al.: Long-term follow-up results of tilt training therapy in patients with recurrent neurocardiogenic syncope. Pacing Clin Electrophysiol 2002, 25:1441\u20131446.","journal-title":"Pacing Clin Electrophysiol"},{"key":"42_CR11","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1161\/01.CIR.0000030939.12646.8F","volume":"106","author":"CT Krediet","year":"2002","unstructured":"Krediet CT, van Dijk N, Linzer M, et al.: Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing. Circulation 2002, 106:1684\u20131689. An important study revealing the value of a simple maneuver (legcrossing with muscle straining) for aborting an imminent reflex faint.","journal-title":"Circulation"},{"key":"42_CR12","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0735-1097(02)02683-9","volume":"40","author":"M Brignole","year":"2002","unstructured":"Brignole M, Croci F, Menozzi C, et al.: Isometric arm counterpressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol 2002, 40:2053\u20132059.","journal-title":"J Am Coll Cardiol"},{"key":"42_CR13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1099-5129(03)00088-6","volume":"5","author":"M Brignole","year":"2003","unstructured":"Brignole M, Donateo P, Menozzi C: The diagnostic value of ATP testing in patients with unexplained syncope. Europace 2003, 5:425\u2013428.","journal-title":"Europace"},{"key":"42_CR14","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(86)91665-X","volume":"1","author":"RA Kenny","year":"1986","unstructured":"Kenny RA, Bayliss J, Ingram A, et al.: Head up tilt: a useful test for investigating unexplained syncope. Lancet 1986, 1:1352\u20131354. The initial landmark paper introducing tilt table testing as a key diagnostic tool for evaluation of neurally mediated syncope.","journal-title":"Lancet"},{"key":"42_CR15","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1540-8159.1999.tb00597.x","volume":"22","author":"M Perez-Paredes","year":"1999","unstructured":"Perez-Paredes M, Pico-Aracil F, Floenciano R, et al.: Head-up tilt test in patients with high prestest likelihood of neurally mediated syncope: an approximation to the \u201creal sensitivity\u201d of this testing. Pacing Clin Electrophysiol 1999, 22:1173\u20131178.","journal-title":"Pacing Clin Electrophysiol"},{"key":"42_CR16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0735-1097(96)00236-7","volume":"28","author":"DG Benditt","year":"1996","unstructured":"Benditt DG, Ferguson DW, Grubb BP, et al.: Tilt table testing for syncope. American College of Cardiology. J Am Coll Cardiol 1996, 28:263\u2013275. Although not a guideline statement, this is the closest publication to guideline that there is in the North American literature dealing with the neurally mediated syncope evaluation.","journal-title":"J Am Coll Cardiol"},{"key":"42_CR17","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1053\/euhj.2001.2739","volume":"22","author":"M Brignole","year":"2001","unstructured":"Brignole M, Alboni P, Benditt DG, et al.: Guidelines on management (diagnosis and treatment) of syncope. Eur Heart 2001, 22:1256\u20131306.","journal-title":"Eur Heart"},{"key":"42_CR18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archpedi.152.2.165","volume":"152","author":"AK Younoszai","year":"1998","unstructured":"Younoszai AK, Franklin WH, Chan DP, et al.: Oral fluid therapy. A promising treatment for vasodepressor syncope. Arch Pediatr Adolesc Med 1998, 152:165\u2013168.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"42_CR19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1540-8159.1998.tb01087.x","volume":"21","author":"H Ector","year":"1998","unstructured":"Ector H, Reybrouck T, Heidbuchel H, et al.: Tilt training: a new treatment for recurrent neurocardiogenic syncope or severe orthostatic intolerance. Pacing Clin Electrophysiol 1998, 21:193\u2013196.","journal-title":"Pacing Clin Electrophysiol"},{"key":"42_CR20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1081\/CEH-120019151","volume":"25","author":"H Abe","year":"2003","unstructured":"Abe H, Sumiyoshi M, Kohshi K, et al.: Effects of orthostatic selftraining on head-up tilt testing for the prevention of tiltinduced nearocardiogenic syncope: comparison of pharmocological therapy. Clin Exper Hypertens 2003, 25:191\u2013198.","journal-title":"Clin Exper Hypertens"},{"key":"42_CR21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/eupc.2001.0191","volume":"3","author":"M Brignole","year":"2001","unstructured":"Brignole M, Alboni P, Benditt D, et al.: Task force on syncope, European Society of Cardiology. Part II. Diagnostic tests and treatment: summary of recommendations. Europace 2001, 3:261\u2013268.","journal-title":"Europace"},{"key":"42_CR22","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1161\/01.CIR.0000030939.12646.8F","volume":"106","author":"CT Krediet","year":"2002","unstructured":"Krediet CT, van Dijk N, Linzer M, et al.: Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing. Circulation 2002, 106:1684\u20131689.","journal-title":"Circulation"},{"key":"42_CR23","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0735-1097(02)02683-9","volume":"40","author":"M Brignole","year":"2002","unstructured":"Brignole M, Croci F, Menozzi C, et al.: Isometric arm counterpressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol 2002, 40:2053\u20132059.","journal-title":"J Am Coll Cardiol"},{"key":"42_CR24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1023\/A:1021795022380","volume":"6","author":"B Ditto","year":"2003","unstructured":"Ditto B, Wilkins JA, France CR, et al.: On-site training in applied muscle tension to reduce vasovagal reactions to blood donation. J Behav Med 2003, 6:53\u201365.","journal-title":"J Behav Med"},{"issue":"Suppl 1","key":"42_CR25","first-page":"227","volume":"1","author":"DP Melby","year":"2004","unstructured":"Melby DP, Lu F, Sakaguchi S, et al.: A novel inspiratory impedance device may diminish orthostatic intolerance. Heart Rhythm 2004, 1(Suppl 1):227.","journal-title":"Heart Rhythm"},{"key":"42_CR26","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/01.CIR.100.11.1242","volume":"100","author":"DG Benditt","year":"1999","unstructured":"Benditt DG, Fahy GJ, Lurie KG, et al.: Pharmacotherapy of neurally mediated syncope. Circulation 1999, 100:1242\u20131248.","journal-title":"Circulation"},{"key":"42_CR27","first-page":"191","volume":"1","author":"AP Fitzpatrick","year":"1991","unstructured":"Fitzpatrick AP, Ahmed R, Williams S, et al.: A randomized trial of medical therapy in malignant vasovagal syndrome or neurally mediated bradycardia\/hypotension syndrome. Eur Card Pacing Electrophysiol 1991, 1:191\u2013202.","journal-title":"Eur Card Pacing Electrophysiol"},{"key":"42_CR28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0002-9149(92)90615-6","volume":"70","author":"M Brignole","year":"1992","unstructured":"Brignole M, Menozzi C, Gianfranchi L, et al.: A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 1992, 70:339\u2013342.","journal-title":"Am J Cardiol"},{"key":"42_CR29","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/0002-8703(95)90150-7","volume":"130","author":"N Mahanonda","year":"1995","unstructured":"Mahanonda N, Bhuripanyo K, Kangkagate C, et al.: Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J 1995, 130:1250\u20131253.","journal-title":"Am Heart J"},{"key":"42_CR30","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0002-9149(96)00359-1","volume":"78","author":"R Sheldon","year":"1996","unstructured":"Sheldon R, Rose S, Flanagan P, et al.: Effects of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test. Am J Cardiol 1996, 78:536\u2013539.","journal-title":"Am J Cardiol"},{"key":"42_CR31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/hrt.77.3.268","volume":"77","author":"M Biffi","year":"1997","unstructured":"Biffi M, Boriani G, Sabbatani P, et al.: Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine. Heart 1997, 77:268\u2013272.","journal-title":"Heart"},{"key":"42_CR32","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0002-9149(98)00568-2","volume":"82","author":"D Iskos","year":"1998","unstructured":"Iskos D, Dutton J, Scheinman MM, et al.: Usefulness of pindolol in neurocardiogenic syncope. Am J Cardiol 1998, 82:1121\u20131124.","journal-title":"Am J Cardiol"},{"key":"42_CR33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/hrt.79.1.45","volume":"79","author":"CR Ward","year":"1998","unstructured":"Ward CR, Gray JC, Gilroy JJ, et al.: Midodrine: a role in the management of neurocardiogenic syncope. Heart 1998, 79:45\u201349.","journal-title":"Heart"},{"key":"42_CR34","first-page":"833","volume":"43","author":"E Girolamo Di","year":"1998","unstructured":"Di Girolamo E, Di Iorio C, Sabatini P, et al.: Effects of different treatments vs no treatment on neurocardiogenic syncope. Cardiologia 1998, 43:833\u2013837.","journal-title":"Cardiologia"},{"key":"42_CR35","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/01.CIR.99.11.1452","volume":"99","author":"A Raviele","year":"1999","unstructured":"Raviele A, Brignole M, Sutton R, et al.: Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study. Circulation 1999, 99:1452\u20131457.","journal-title":"Circulation"},{"key":"42_CR36","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1046\/j.1540-8167.2001.00935.x","volume":"12","author":"A Perez-Lugones","year":"2001","unstructured":"Perez-Lugones A, Schweikert R, Pavia S, et al.: Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study. J Cardiovasc Electrophysiol 2001, 12:935\u2013938.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"42_CR37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0002-9149(01)01594-6","volume":"88","author":"N Samniah","year":"2001","unstructured":"Samniah N, Sakaguchi S, Lurie KG, et al.: Efficacy and safety of midodrine hydrochloride in patients with refractory vasovagal syncope. Am J Cardiol 2001, 88:80\u201383.","journal-title":"Am J Cardiol"},{"key":"42_CR38","first-page":"833","volume":"43","author":"E Girolamo Di","year":"1998","unstructured":"Di Girolamo E, Di Iorio C, Sabatini P, et al.: Effects of different treatments versus no treatment on neurocardiogenic syncope. Cardiologia 1998, 43:833\u2013837.","journal-title":"Cardiologia"},{"key":"42_CR39","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ana.10293","volume":"52","author":"H Kaufmann","year":"2002","unstructured":"Kaufmann H, Saadia D, Voustianiouk A: Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study. Ann Neurol 2002, 52:342\u2013345.","journal-title":"Ann Neurol"},{"key":"42_CR40","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0002-9149(02)02338-X","volume":"89","author":"R Dendi","year":"2002","unstructured":"Dendi R, Goldstein DS: Meta-analysis of nonselective versus beta-1 adrenoceptor-selective blockade in prevention of tiltinduced neurocardiogenic syncope. Am J Cardiol 2002, 89:1319\u20131321.","journal-title":"Am J Cardiol"},{"key":"42_CR41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1009815304770","volume":"3","author":"DG Benditt","year":"1999","unstructured":"Benditt DG, Sutton R, Gammage M, et al.: Rate-Drop Response Investigators Group. Rate-drop response cardiac pacing for vasovagal syncope. J Interv Card Electrophysiol 1999, 3:27\u201333.","journal-title":"J Interv Card Electrophysiol"},{"key":"42_CR42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0735-1097(98)00549-X","volume":"33","author":"SJ Connolly","year":"1999","unstructured":"Connolly SJ, Sheldon R, Roberts RS, et al.: Vasovagal pacemaker study investigators. The North American vasovagal pacemaker study (VPS): a randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999, 33:16\u201320.","journal-title":"J Am Coll Cardiol"},{"key":"42_CR43","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/01.CIR.102.3.294","volume":"102","author":"R Sutton","year":"2000","unstructured":"Sutton R, Brignole M, Menozzi C, et al.: Dual-chamber pacing in treatment of neurally mediated tilt-positive cardioinhibitory syncope. Pacemaker versus no therapy: a multicentre randomized study. Circulation 2000, 102:294\u2013299.","journal-title":"Circulation"},{"key":"42_CR44","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/hc2601.091708","volume":"104","author":"F Ammirati","year":"2001","unstructured":"Ammirati F, Colivicchi F, Santini M, et al.: Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope. A multicenter, randomized, controlled trial. Circulation 2001, 104:52\u201356.","journal-title":"Circulation"},{"key":"42_CR45","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1001\/jama.289.17.2224","volume":"289","author":"S Connolly","year":"2003","unstructured":"Connolly S, Sheldon R, Thorpe KE, et al.: Pacemaker therapy for prevention of syncope in patients with recurrent vasovagal syncope. JAMA 2003, 289:2224\u20132229. Randomized, controlled study evaluating the efficacy of pacemaker therapy in patients with recurrent vasovagal syncope. Results showed a nonsignificant reduction in time to recurrent syncope in the pacemaker group.","journal-title":"JAMA"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-004-0042-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-004-0042-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-004-0042-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:55:59Z","timestamp":1559433359000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-004-0042-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["42"],"URL":"https:\/\/doi.org\/10.1007\/s11886-004-0042-7","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}